Scholar Rock Holding Corp. SRRK

Scholar Rock Clears FDA Hurdle With First Muscle-Targeted SMA Drug

ISEMBYLD approval moves Scholar Rock into commercialization after a manufacturing setback delayed its first attempt last year.